The Cancer Cell Line Encyclopedia
Powered by SNPnexus
Overview
Help
Disease Type
ER Status
PR Status
HER2 Status
Loading...
There are patients available from the BCN Biobank that match the selected/a subset of the criteria. Explore the data available for these patients using our Cohort Browser.
Researchers can request samples from BCNB website to support their research activities.
*Based on your filtering criteria you can view the number of available patients and associated samples in BCNBIn order to apply for samples, please use the BCNB Request System to submit an Expression of interest (EOI) form.
If you require further details please contact us at tissue.bank@breastcancernow.org
| Cell line | Age at Diagnosis | Sex | Ethnicity | Cell type | ER | PR | HER2 | Tissue | Disease |
|---|---|---|---|---|---|---|---|---|---|
| SUM149PT | NA | NA | NA | NA | negative | negative | negative | NA | ductal carcinoma |
| SUM159PT | NA | NA | NA | NA | negative | negative | negative | NA | anaplastic carcinoma |
| SUM229PE | NA | NA | NA | NA | negative | negative | negative | derived from metastatic site:pleural effusion | NA |
| HCC1143 | 52.0 | female | caucasian | epithelial | NA | NA | negative | mammary gland;duct | ductal carcinoma |
| HCC1395 | 43.0 | female | caucasian | epithelial;lymphoblast | NA | NA | negative | breast;duct | ductal carcinoma |
| HMC18 | NA | female | NA | NA | negative | NA | negative | metastasis | carcinoma |
| HS274T | NA | female | NA | NA | NA | NA | NA | fibroblast | NA |
| HS578T | 74.0 | female | caucasian | epithelial | negative | NA | NA | breast | carcinoma |
| JIMT1 | 62.0 | female | NA | NA | negative | NA | positive | metastasis | ductal carcinoma |
| MDAMB415 | 38.0 | female | caucasian | NA | NA | NA | NA | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB436 | 43.0 | female | caucasian | NA | NA | NA | NA | derived from metastatic site:pleural effusion | adenocarcinoma |
| ZR751 | 63.0 | female | caucasian | epithelial | positive | NA | NA | derived from metastatic site:ascites | ductal carcinoma |
| AU565 | 43.0 | female | caucasian | NA | NA | NA | positive | derived from metastitic site:malignant pleural effusion | adenocarcinoma |
| BT20 | 74.0 | female | caucasian | epithelial | negative | NA | NA | breast | carcinoma |
| BT474 | 60.0 | female | caucasian | epithelial | positive | NA | positive | breast;duct | ductal carcinoma |
| BT483 | 23.0 | female | caucasian | epithelial | positive | NA | negative | breast | ductal carcinoma |
| CAL120 | 43.0 | female | NA | NA | negative | NA | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| CAL51 | 45.0 | female | NA | NA | negative | NA | negative | derived from metastatic site:pleural effusion | carcinoma |
| CAL851 | 35.0 | female | NA | NA | negative | NA | negative | primary | galactophoric breast adenocarcinoma |
| CAMA1 | 51.0 | female | caucasian | epithelial | positive | NA | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| DU4475 | 70.0 | female | caucasian | carcinoma;skin | negative | NA | negative | derived from metastatic site:skin carcinoma | NA |
| EFM192A | 46.0 | female | NA | NA | positive | NA | positive | derived from metastatic site:pleural effusion | adenocarcinoma |
| EFM19 | 50.0 | female | caucasian | NA | positive | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| HCC1187 | 41.0 | female | caucasian | epithelial | NA | NA | negative | breast | ductal carcinoma |
| HCC1419 | 42.0 | female | hispanic | epithelial | negative | negative | NA | breast | ductal carcinoma |
| HCC1428 | 49.0 | female | caucasian | epithelial | NA | NA | negative | derived from metastatic site:adenocarcinoma and pleural effusion | adenocarcinoma |
| HCC1500 | 32.0 | female | black | epithelial | positive | positive | negative | gland;duct | ductal carcinoma |
| HCC1569 | 70.0 | female | black | epithelial | negative | negative | positive | breast | metaplastic carcinoma |
| HCC1599 | 44.0 | female | caucasian | epithelial;lymphoblast | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC1937 | 23.0 | female | caucasian | epithelial;lymphoblast | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC1954 | 61.0 | female | east Indian | epithelial | negative | negative | positive | breast;duct | ductal carcinoma |
| HCC202 | 82.0 | female | caucasian | epithelial | negative | negative | positive | gland;duct | ductal carcinoma |
| HCC2157 | 48.0 | female | black | epithelial | negative | negative | positive | gland;breast | ductal carcinoma |
| HCC38 | 50.0 | female | caucasian | epithelial | negative | negative | negative | breast;duct | ductal carcinoma |
| HCC70 | 49.0 | female | black | epithelial | NA | NA | negative | breast;duct | ductal carcinoma |
| HDQP1 | 50.0 | female | caucasian | NA | negative | negative | negative | primary | ductal carcinoma |
| MCF7 | 69.0 | female | caucasian | epithelial | positive | NA | NA | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB134VI | 47.0 | female | caucasian | epithelial | positive | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| MDAMB157 | 44.0 | female | black | epithelial | negative | NA | negative | breast;medulla | medulallary carcinoma |
| MDAMB175VII | 56.0 | female | black | epithelial | negative | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| MDAMB231 | 51.0 | female | caucasian | epithelial | negative | NA | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MDAMB361 | 40.0 | female | caucasian | epithelial | positive | NA | positive | derived from metastatic site:brain | adenocarcinoma |
| MDAMB453 | 48.0 | female | caucasian | epithelial | negative | NA | negative | derived from metastatic site:pericardial effusion | metastatic carcinoma |
| T47D | 54.0 | female | NA | epithelial | positive | positive | NA | derived from metastatic site:pleural effusion | ductal carcinoma |
| UACC812 | 43.0 | female | NA | epithelial | negative | negative | positive | breast | ductal carcinoma |
| UACC893 | 57.0 | female | caucasian | epithelial | negative | negative | positive | breast | ductal carcinoma |
| BT549 | 72.0 | female | caucasian | epithelial | negative | NA | negative | breast | ductal carcinoma |
| CAL148 | 58.0 | female | french | NA | negative | NA | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| COLO824 | 52.0 | female | NA | NA | NA | NA | NA | derived from metastatic site:pleural effusion | carcinoma |
| EVSAT | NA | female | NA | NA | negative | positive | NA | derived from metastatic site:ascitic effusion | carcinoma |
| HCC1806 | 60.0 | female | black | epithelial | negative | negative | negative | breast | acantholytic squamous cell carcinoma |
| HCC2218 | 38.0 | female | caucasian | epithelial;lymphoblast | negative | NA | positive | breast;duct | ductal carcinoma |
| MDAMB330 | 43.0 | female | caucasian | epithelial | NA | NA | NA | derived from metastatic site:pleural effusion | infiltrating lobular carcinoma |
| MDAMB468 | 51.0 | female | black | epithelial | negative | NA | negative | derived from metastatic site:pleural effusion | adenocarcinoma |
| MFM223 | NA | female | NA | NA | negative | NA | negative | metastasis | NA |
| MRKNU1 | NA | NA | NA | NA | NA | NA | NA | breast | carcinoma |
| OCUBM | NA | NA | NA | NA | NA | NA | NA | breast | carcinoma |
| YMB1E | NA | NA | NA | NA | NA | NA | NA | breast | ductal carcinoma |
| ZR7530 | 47.0 | female | black | epithelial | NA | NA | NA | derived from metastatic site:ascites | ductal carcinoma |
| HMEL | NA | NA | NA | NA | NA | NA | NA | engineered breast | NA |
| KPL1 | NA | female | japanese | NA | positive | negative | negative | derived from metastatic site:pleural effusion | ductal carcinoma |
| SKBR3 | 43.0 | female | caucasian | epithelial | NA | NA | positive | derived from metastatic site:pleural effusion | adenocarcinoma |